OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An updated literature on BRAF inhibitors (2018–2023)
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2689-2730
Closed Access | Times Cited: 12
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2689-2730
Closed Access | Times Cited: 12
Showing 12 citing articles:
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
I. Aayishamma, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116831-116831
Closed Access | Times Cited: 8
I. Aayishamma, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116831-116831
Closed Access | Times Cited: 8
Explanatory review on DDR inhibitors: their biological activity, synthetic route, and structure–activity relationship
Sindhuja Sengupta, Lalmohan Maji, Pronoy Kanti Das, et al.
Molecular Diversity (2025)
Closed Access
Sindhuja Sengupta, Lalmohan Maji, Pronoy Kanti Das, et al.
Molecular Diversity (2025)
Closed Access
Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomas
Tian Gao, Xinyu He, Junyi Wang, et al.
Cell Reports Medicine (2025), pp. 101990-101990
Open Access
Tian Gao, Xinyu He, Junyi Wang, et al.
Cell Reports Medicine (2025), pp. 101990-101990
Open Access
An innovative approach to development of new pyrazolylquinolin-2-one hybrids as dual EGFR and BRAFV600E inhibitors
Mohamed M. Hawwas, Ahmed S. Mancy, Mohamed Ramadan, et al.
Molecular Diversity (2025)
Open Access
Mohamed M. Hawwas, Ahmed S. Mancy, Mohamed Ramadan, et al.
Molecular Diversity (2025)
Open Access
Precision Medicine in High-Grade Serous Ovarian Cancer: Targeted Therapies and the Challenge of Chemoresistance
Sara Polajžer, Katarina Černe
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2545-2545
Open Access
Sara Polajžer, Katarina Černe
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2545-2545
Open Access
A Comprehensive Review of RAF Kinase: Advances in Inhibition Strategies for Drug Development
Dilay Kahvecioglu
Journal of Molecular Structure (2025), pp. 142206-142206
Closed Access
Dilay Kahvecioglu
Journal of Molecular Structure (2025), pp. 142206-142206
Closed Access
Detection of postoperative recurrence in colorectal cancer: Exploring the value of liquid biopsy
В. В. Костюченко, Ihor Vynnychenko, Yuliia Moskalenko, et al.
Regulatory Mechanisms in Biosystems (2025) Vol. 33, Iss. 1, pp. e25020-e25020
Open Access
В. В. Костюченко, Ihor Vynnychenko, Yuliia Moskalenko, et al.
Regulatory Mechanisms in Biosystems (2025) Vol. 33, Iss. 1, pp. e25020-e25020
Open Access
Correlation analysis between BRAFV600E mutation and ultrasonic and clinical features of papillary thyroid cancer
Jiahao Wen, Haizhou Liu, Yanyan Lin, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29955-e29955
Open Access | Times Cited: 2
Jiahao Wen, Haizhou Liu, Yanyan Lin, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29955-e29955
Open Access | Times Cited: 2
Identification of a novel genomic variance of BRAF1 in papillary thyroid carcinoma: A case report
Yuguo Wang, Jian Zhao, Zhihan Tan, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36978-e36978
Open Access | Times Cited: 1
Yuguo Wang, Jian Zhao, Zhihan Tan, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36978-e36978
Open Access | Times Cited: 1
BRAF V600E Mutation in Malignant Melanoma—A Romanian Research Experience
Elena-Roxana Avădănei, Irina-Draga Căruntu, Irina Nucă, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 351-351
Open Access | Times Cited: 1
Elena-Roxana Avădănei, Irina-Draga Căruntu, Irina Nucă, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 351-351
Open Access | Times Cited: 1
Exploring the Anticancer Potential of Triazine Derivatives: An Outlook of Designing Strategies, Docking Studies, and Structure‐Activity Relationships (SAR)
B V Manjushree, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Open Access | Times Cited: 1
B V Manjushree, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Open Access | Times Cited: 1
Reaction strategies for the meta-selective functionalization of pyridine through dearomatization
Jie Lei, Zhigang Xu
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 849-869
Closed Access
Jie Lei, Zhigang Xu
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 849-869
Closed Access
Molecular Docking: An Emerging Tool for Target-Based Cancer Therapy
Pavithra Uppathi, Suraj Rajakumari, K. V. Saritha
Critical Reviews™ in Oncogenesis (2024) Vol. 30, Iss. 1, pp. 1-13
Closed Access
Pavithra Uppathi, Suraj Rajakumari, K. V. Saritha
Critical Reviews™ in Oncogenesis (2024) Vol. 30, Iss. 1, pp. 1-13
Closed Access
